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Abstract
Background: Enhanced Recovery After Surgery (ERAS) is a perioperative management based on multimodality and
multidisciplinary work. ERAS has been shown to have important clinical and economic benefits, but its spread
remains slow worldwide.
Discussion: This manuscript reviews the overall program benefits and focuses on important aspects for
implementation well beyond surgery.
Summary: Implementation of ERAS pathways improves clinical outcomes and induces substantial economic gains.
ERAS is the current surgical revolution.
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Background
While surgeons mainly focus on techniques and tech-
nologies, new strategies that affect system performance
offer many benefits for patients, healthcare providers,
and health systems. Enhanced Recovery After Surgery
(ERAS) is a systematized and validated perioperative
management model based on best available evidence [1].
ERAS pathways decrease surgical stress, maintain
physiological homeostasis, and improve postoperative
recovery [1]. ERAS is a multidisciplinary management
strategy encompassing several items and interventions,
challenging old dogmas such as preoperative fasting [1].
The success of ERAS pathways depends on clinical lead-
ership, site coordination, application of evidence-based
care protocol items without any patient selection, and
continuous audit of the outcomes and processes behind
the performance [2]. The international ERAS® Society
(www.erassociety.org) has published evidence-based
guidelines for many surgical procedures. Implementation
of these ERAS guidelines have been shown to substantially
reduce postoperative complications, length of stay (LOS)
and overall costs, and to increase both patient and staff
satisfaction [3–5]. Two recent reports also suggested that
ERAS implementation may be associated with improved
long-term survival [2, 6].
There is limited documentation of the spread and
scale of ERAS protocols across hospitals, stakeholders,
and health systems, in a time when health systems are
under increasing pressure for improved care at lower
cost. This short article aims to analyze important clinical
and economic outcomes of ERAS implementation to
support healthcare providers and managers in their deci-
sion making to sustain and improve health care.
Due to changing demography and advancements in
anesthesiology and in surgical strategies, hospitals will use
a growing part of their bed capacity for complex multi-
morbid surgical patients. A strategy will therefore be
needed to develop hospital capacity in a rational way.
There is evidence showing that variation in care provision
and outcomes is huge at almost every level – between
countries, within countries, within hospitals, and often
between individual doctors. The main reason for these
discrepancies is that few evidence-based treatments are
used and measured. Evidence-based standard processes
should be defined and tracked to minimize unnecessary
variation in care and allow timely escalation procedures in
non-standard situations. The goal is optimal use of
economic resources and clinical interventions to reach
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equitable and efficient care. ERAS fits in this global
approach. It includes process standardization and mea-
surement, as well as interdisciplinary and systematic im-
provement methods to put in place a sustainable system
for continuous enhanced care. In addition, ERAS fulfills
the recently described Quadruple Aim: achieving better
patient outcomes, at lower cost, with improved patient,
medical, nursing, and provider satisfaction [7].
Impact of ERAS on morbidity and costs
The major positive consequence of implementing ERAS
pathways is improvement of patient outcomes at decreased
costs. Several studies suggest that ERAS decreased postop-
erative complications. In colorectal surgery, a meta-analysis
of 16 randomized trials with 2376 patients showed de-
creased postoperative morbidity by 40% (RR = 0.6, 95% CI:
0.46–0.76) [3]. In pancreas surgery, a meta-analysis of 14
non-randomized studies also showed a diminution of over-
all morbidity (OR = 0.63, 95% CI: 0.54–0.74) [8]. In liver
surgery, complications were decreased by 30 to 50% [4, 9].
It may be surprising that a sum of relatively simple
perioperative measures such as early mobilization and oral
alimentation impacts patient outcomes that much. This
highlights the power of all ERAS items working together
rather than single elements only and assessing their individ-
ual application. However, the physiologic and underlying
mechanisms of ERAS remain debated and subject to inves-
tigations. Pathophysiology and improved immunity play a
role, but standardization of clinical pathways probably has
an important influence as well. Moreover, the decrease in
complications is partly responsible for the decreased LOS
observed in ERAS patients. Of note, faster hospital dis-
charge with ERAS does not result in increased readmission
rates [3].
In decreasing complications, ERAS protocols produced
reduced LOS and costs. Several reports from Europe and
North America measured ERAS cost savings. For ex-
ample, in colorectal, pancreas, and liver surgery, a Swiss
university hospital measured reductions of €1651, €7738,
and €3080 per patient, respectively, accounting for almost
$1 million USD cost savings for the 198 assessed patients
in these three studies [5, 10, 11]. In Canada, implementa-
tion of ERAS across an entire provincial healthcare system
in Alberta showed net cost savings ranging from $2806 to
$5898 USD per patient in a cohort of consecutive colorec-
tal patients [12]. Thus, ERAS was cost-beneficial and also
cost-effective as complications were decreased. Cost sav-
ings in colorectal surgery were more substantial in Canada
than in Switzerland in the mentioned studies. Overall
complication and readmission rates were decreased in the
Canadian study, whereas no difference was noted in the
Swiss article. This can be a potential explanation for the
observed difference in cost reduction. Moreover, in
Canada, ERAS was implemented across an entire health
care system (Alberta province) compared to Swiss data
originating from one single center, which can induce more
substantial cost savings globally. Finally, salary (e.g., ERAS
nurse) and material costs are probably less expensive in
Canada (Switzerland is a known expensive country),
allowing cheaper specific ERAS costs of implementation
in Canada. Even if primary investments are necessary, re-
turn on investment is substantial, reported at a factor of
four [13]. As ERAS induces cost savings per patient, the
more patients enrolled, the more savings. Important
factors for ERAS long-term success are changes in ma-
nagement of care processes and time investment to form
a multidisciplinary and multiprofessional ERAS team
along with the use of dedicated protocols, continuous
audit, and feedback [13].
ERAS implementation
A barrier for ERAS implementation may be the reluctance
of managers to invest in ERAS team building, database, and
systematic audit [13]. A way to overcome the barriers faced
for global ERAS implementation might be to increase
objective data on financial benefits of ERAS, as shown in
recent publications on ERAS costs. Another possibility
could be to improve awareness of the advantages of an
ERAS management (via advertisements or information
campaigns) in the general population, which could con-
vince the managers to invest in such successful programs.
To diminish primary investments, ERAS implementation
on multiple sites at the same time across an entire health
care system or a specific geographical area could be realized
with substantial lower costs. The real question to ask would
be: what does a hospital lose by not applying ERAS? For ex-
ample positive clinical and economic impact of expansive
new surgical technologies has not been demonstrated yet.
Investments in robotic surgery are made at a cost 20 times
higher than investment in ERAS. It is surprising that de-
partments that invested in new technologies did not invest
in ERAS first in order to improve care and save money.
Cost savings from ERAS implementation could then as a
result be used to invest in new technologies. In fact, cost
savings possibly induced by new technologies remain to be
unequivocally demonstrated [14, 15]. Technology advance-
ments are of course important in surgery, but perioperative
management goes far beyond surgical technique in terms
of impact on outcomes and costs and can be introduced
with lower investment. Moreover, chairs of surgical depart-
ments might be hostile to ERAS implementation because it
would mean important changes in their clinical habits and
established management pathways. Another obstacle may
also be the fact that many centers are claiming to apply
ERAS already, but without controlled application of proto-
cols and ERAS pathways.
It has been demonstrated that ERAS positively influences
patient subjective well-being with better health-related
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quality of life, less pain or fatigue, and better patient
satisfaction [16, 17]. ERAS puts the patient in the center of
its perioperative management and recovery team and em-
powers him or her by increasing motivation to recover
quickly and accepting responsibilities in their own manage-
ment and recovery plan. In major gynecologic surgery, a
before-and-after ERAS implementation study reported sig-
nificantly better pain control and better patient information
[18]. Patient information and education, as well as
increased communication are often neglected key factors in
the surgical process.
ERAS is also well accepted and supported by medical
and nursing staff. Some prospective data from Switzerland
suggested that overall nursing workload was decreased
after ERAS implementation [19]. Workload was assessed
by a standardized and validated point system (PRN) and
decreased by about 15% [19]. Furthermore, higher compli-
ance to ERAS protocols was associated with reduced
nursing workload [19]. In another report, paramedical
staff described ERAS as a successful change without com-
promising workload and work environment of the nursing
staff, confirming good general appraisal of ERAS by care
providers [20].
Conclusions
With health systems worldwide looking at sustainable
ways to achieve the above mentioned Quadruple Aim,
ERAS provides an evidence-based solution for surgical
patients [7]. This surgical transformation significantly
improves system performances both clinically and finan-
cially. The concept has been proven for almost every
major operation, and ERAS implementation programs
have been successfully implemented in more than 30
countries around the world [13]. ERAS is not a pilot
project anymore with more than 35,000 patients in-
cluded worldwide in late 2017.
Therefore, why does ERAS not spread faster? Perhaps is
ERAS wrongly viewed as improvement for selected
patients and specific operations? In fact ERAS is a means
to transform perioperative management for all surgical pa-
tients without any selection within an entire hospital. In
addition the implementation needs initial investments
with a systematic implementation course instead of simple
user notice and time to implement and run ERAS with
dedicated resources to support the changes at a unit and
site level. This may be perceived negatively because cost
savings are not necessarily achieved in the same budgets
where the changes are made. In some units there is also a
lack of clinical leadership to change for ERAS. Imple-
mentation needs work, time, and investment, and ERAS is
not magic, but just the systematic application of an
evidence-based protocol that drives surgical transform-
ation. It is necessary that boardrooms where investment
decisions are made understand the process, support
clinicians to make the required changes that repeatedly
demonstrated the overwhelming clinical and financial
benefits, and include ERAS in the hospital business plan
(Table 1). Moreover, sustainability and viability of ERAS
should be taken into consideration (since savings are
made for every enrolled patient). However, to enjoy the fi-
nancial gains across a hospital setting, making spread and
scale of ERAS protocols an expectation for every hospital
will facilitate the gains more quickly. In the future, expan-
sion of ERAS in low- and middle-income countries might
be challenging, because investments are difficult to obtain.
In addition, implementation of ERAS across entire health
care systems will be a demanding but necessary task to de-
velop ERAS internationally. Finally, ERAS pathway has to
be adaptable to local conditions in various countries and
evolves over time as the scientific evidence grows. ERAS
is the current surgical revolution to improve clinical out-
comes and economic efficiency in health care systems, far
beyond surgical techniques and technologies. The main
questions remaining are – what are managers and leaders
waiting for? And how long will patients still accept treat-
ment at a non-ERAS hospital?
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